Emerging Markets Regulatory Tracker: Brazil (Vol. 4 No. 22)
This article was originally published in PharmAsia News
Executive Summary
Brazil’s Anvisa considers nanotechnology evaluations with a need for a cautious approach, while the country’s Ministry of Environment issues an April 6 deadline for environment-friendly plan to dispose of medicines.